These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 1055406

  • 1. Patients with Ehlers-Danlos syndrome type IV lack type III collagen.
    Pope FM, Martin GR, Lichtenstein JR, Penttinen R, Gerson B, Rowe DW, McKusick VA.
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1314-6. PubMed ID: 1055406
    [Abstract] [Full Text] [Related]

  • 2. Ehlers-Danlos syndrome type IV D: an autosomal recessive disorder.
    Sulh HM, Steinmann B, Rao VH, Dudin G, Zeid JA, Slim M, Der Kaloustian VM.
    Clin Genet; 1984 Mar; 25(3):278-87. PubMed ID: 6705261
    [Abstract] [Full Text] [Related]

  • 3. Ehlers-Danlos syndrome type IV (EDS IV) as model of a defective biopolymer composite material.
    Nemetschek T, Folkhard W, Knörzer E, Mosler E, Nemetschek-Gansler H, Koch MH, Meinel A, Romen W.
    Connect Tissue Res; 1989 Mar; 18(4):269-76. PubMed ID: 2743768
    [Abstract] [Full Text] [Related]

  • 4. Impaired secretion of type III procollagen in Ehlers-Danlos syndrome type IV fibroblasts: correction of the defect by incubation at reduced temperature and demonstration of subtle alterations in the triple-helical region of the molecule.
    Superti-Furga A, Steinmann B.
    Biochem Biophys Res Commun; 1988 Jan 15; 150(1):140-7. PubMed ID: 3337712
    [Abstract] [Full Text] [Related]

  • 5. [Structural characteristics of collagens from the skin and rib cartilage of patients with Ehlers-Danlos syndrome type II].
    Sokolov BP, Sher BM, Kozlov EA, Tsvetkova TA, Rudakov SS, Del'vig AA, Kalinin VN.
    Vopr Med Khim; 1990 Jan 15; 36(1):90-3. PubMed ID: 2343586
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Detection of type III collagen in skin fibroblasts from patients with Ehlers-Danlos syndrome type IV by immunofluorescence.
    Temple AS, Hinton P, Narcisi P, Pope FM.
    Br J Dermatol; 1988 Jan 15; 118(1):17-26. PubMed ID: 3277658
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Various characteristics of the structure and synthesis of procollagens produced by cultured skin fibroblasts from patients with Danlos-Ehlers syndrome type I].
    Sokolov BP, Sher BM, Lomova TIu, Kukharenko VI, Blinnikova OE.
    Mol Gen Mikrobiol Virusol; 1987 Jan 15; (1):19-23. PubMed ID: 3561422
    [Abstract] [Full Text] [Related]

  • 11. Another mechanism for the defect in type III collagen accumulation in Ehlers-Danlos syndrome type IV: increased intracellular degradation of the procollagen.
    Utani A, Tanaka T, Nishigori C, Miyachi Y, Danno K, Imamura S, Hosokawa M, Takeda T, Hirayoshi K, Nagata K.
    Lab Invest; 1990 Aug 15; 63(2):181-8. PubMed ID: 2199725
    [Abstract] [Full Text] [Related]

  • 12. Quantitation of types I and III collagens in human tissue samples and cell culture by cyanogen bromide peptide analysis.
    Hill RJ, Harper E.
    Anal Biochem; 1984 Aug 15; 141(1):83-93. PubMed ID: 6496939
    [Abstract] [Full Text] [Related]

  • 13. Synthesis of an altered type III procollagen in a patient with type IV Ehlers-Danlos syndrome. A structural change in the alpha 1(III) chain which makes the protein more susceptible to proteinases.
    Stolle CA, Pyeritz RE, Myers JC, Prockop DJ.
    J Biol Chem; 1985 Feb 10; 260(3):1937-44. PubMed ID: 2981879
    [Abstract] [Full Text] [Related]

  • 14. Defect in conversion of procollagen to collagen in a form of Ehlers-Danlos syndrome.
    Lichtenstein JR, Martin GR, Kohn LD, Byers PH, McKusick VA.
    Science; 1973 Oct 19; 182(4109):298-300. PubMed ID: 4742738
    [Abstract] [Full Text] [Related]

  • 15. Altered secretion of type III procollagen in a form of type IV Ehlers-Danlos syndrome. Biochemical studies in cultured fibroblasts.
    Byers PH, Holbrook KA, Barsh GS, Smith LT, Bornstein P.
    Lab Invest; 1981 Apr 19; 44(4):336-41. PubMed ID: 6259441
    [Abstract] [Full Text] [Related]

  • 16. Enzyme-linked immunoassay and electrophoretic separation of collagens secreted by cultured skin fibroblasts of patients with Ehlers-Danlos and Marfan syndromes.
    Borisova NV, Safronova EE, Krasnopol'skaya KD, Blinnikova OE, Polyudov SA.
    Biomed Sci; 1991 Apr 19; 2(5):523-9. PubMed ID: 1840842
    [Abstract] [Full Text] [Related]

  • 17. Low levels of serum type III procollagen aminoterminal propeptide confirmed type III collagen deficiency in patients without typical clinical symptoms of Ehlers-Danlos type IV.
    Dyne KM, Zanaboni G, Annoni G, De Agostini MP, Cetta G.
    Eur J Clin Invest; 1989 Aug 19; 19(4):362-6. PubMed ID: 2506053
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Collagen type I, III, IV and V and fibronectin in skin biopsies of patients with Ehlers-Danlos syndrome and cutis laxa].
    Shekhonin BV, Semiachkina AN, Makkaev KhM, Domogatskiĭ SP, Idel'son GL.
    Arkh Patol; 1988 Aug 19; 50(12):41-8. PubMed ID: 3074749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.